Athira Pharma Inc.

NASDAQ: ATHA · Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM

Athira Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 969K 1.05M 479K
Gross Profit
n/a -969K -1.05M -479K
Operating Income
-96.78M -125.47M -104.02M -64.02M
Interest Income
n/a 7.64M 3.22M 337K
Pretax Income
-96.94M -117.67M -95.64M -54.85M
Net Income
-96.94M -117.67M -87.26M -54.37M
Selling & General & Admin
26.09M 33.3M 32.55M 21.23M
Research & Development
70.68M 92.82M 61.46M 42.79M
Other Expenses
n/a -1.63M -5.16M -8.84M
Operating Expenses
100.9M 125.47M 88.86M 55.19M
Interest Expense
n/a n/a 24.32M 3K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 125.47M 88.86M 55.19M
Income Tax Expense
n/a n/a -8.38M -479K
Shares Outstanding (Basic)
38.48M 38.02M 37.73M 36.92M
Shares Outstanding (Diluted)
38.48M 38.02M 37.73M 36.92M
EPS (Basic)
-2.52 -3.09 -2.31 -1.47
EPS (Diluted)
-2.52 -3.09 -2.31 -1.47
EBITDA
-95.97M -116.7M -94.59M -54.37M
EBIT
-96.94M -117.67M -95.64M -54.85M
Depreciation & Amortization
970K 969K 1.05M 479K